Charles L. Vogel MD FACP performed the early clinical trials involving Herceptin as a Monotherapy. The article also addresses other issues relating to the treatment of HER-2 positive breast cancer. BCU 2: 2003
|
All times are GMT -7. The time now is 10:05 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021